95.ISGNqbFcT3c9uRqjpFmF6IlO_vOXYPZvjD-6kxmAdZg.ZAzakMAQCDpezmvqyTXfp-I5y6PeWYIC-E_Oo3XsG_FyYv_i4DECIWzNSw
22-11-07 Mana Capital Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
22-10-31 MANA CAPI : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K PU
22-10-26 Mana Capital, Cardio Diagnostics Complete Merger MT
22-10-25 Mana Capital Acquisition Corp.(NasdaqGM:MAAQ) dropped from NASDAQ Composite Index CI
22-10-24 Cardio Diagnostics Inc. completed the acquisition of Mana Capital Acquisition Corp. from a group of shareholders in a reverse merger transaction. CI
22-10-10 Mana Capital Acquisition Corp. Announces Effectiveness of Registration Statement and October 25, 2022 Special Meeting of Stockholders to Approve Business Combination with Cardio Diagnostics, Inc. BU
22-09-23 MANA CAPITAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits (form 8-K) AQ
22-09-23 Mana Capital Acquisition Corp. Confirms Second Contribution to Trust Account to Extend Time Period to Complete a Business Combination BU
22-09-22 Mana Capital Acquisition Corp. Announces Intention to Further Extend Period to Consummate Initial Business Combination BU
22-09-21 Mana Capital Acquisition : Cardio Diagnostics Announces Issuance of U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease - Form 8-K PU
22-09-21 MANA CAPITAL ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
22-09-15 MANA CAPITAL ACQUISITION CORP. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) AQ
22-08-26 MANA CAPITAL ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
22-08-25 MANA CAPITAL ACQUISITION CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events, Financial Statements and Exhibits (form 8-K) AQ
22-08-25 Mana Capital Acquisition Corp. Confirms Contribution to Trust Account to Extend Time Period to Complete a Business Combination BU
22-08-23 Mana Capital Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination BU
22-08-10 MANA CAPITAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) AQ
22-08-10 Mana Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
22-05-31 Mana Capital Acquisition : and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics - Form 8-K PU
22-05-31 MANA CAPITAL ACQUISITION CORP. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) AQ
22-05-31 Cardio Diagnostics to Go Public Through Merger With Mana Capital Acquisition MT
22-05-31 Mana Capital Acquisition Corp. and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics BU
22-05-30 Cardio Diagnostics Inc. entered into a definitive business combination agreement to acquire Mana Capital Acquisition Corp. from a group of shareholders for approximately $110 million in a reverse merger transaction. CI
22-05-12 MANA CAPITAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) AQ
22-05-12 Mana Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI

Become a member to access more news

New member
No results match your criteria